LIGNAN ANTITUMOR PROTOTYPES VIA DIANION INTERMEDIATES
LIGNAN ANTITUMOR PROTOTYPES VIA DIANION INTERMEDIATES
批准号:
3179644
负责人:
JOHN L BELLETIRE
金额:
$5.28万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1985
资助国家:
美国
项目状态:
已结题
起止时间:
1985-09-30 至 1989-07-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The specific goal of this proposal is the synthesis of a series of
increasingly challenging lignan natural products culminating in the
efficient preparation of two antitumor prototypes: steganacin and
podophyllotoxin. Development of such sequences should prove especially
useful for exploration of structure-activity relationships among analogs to
these promising agents.
Dianion intermediates exhibit extraordinary reactivity towards
electrophiles. Preliminary studies have demonstrated that carboxylic acid
dianions can be either dimerized or iodinated simply by varying the
stoichiometry of added I2. Building upon this simple transformation,
numerous symmetrically- and unsymmetrically-submitted succinic acid
derivatives (including anhydrides, lactones, and amides) become readily
available.
Key synthetic steps to be explored in the generation of both steganacin and
podophyllotoxin include reaction of amide dianions with 2-iodocarboxylates,
selective reduction of the resulting acid-amide products, and
intramolecular photochemically-driven iodination using N-iodoamide
precursors.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Stereoselectivity questions in the synthesis of wikstromol.
wikstromol 合成中的立体选择性问题。
DOI:
10.1021/np50072a034
发表时间:
1990
期刊:
Journal of natural products
影响因子:
5.1
作者:
[Belletire,JL, Ho,DM, Fry,DF]
通讯作者:
Fry,DF
The role of dianion coupling in the synthesis of dibenzylbutane lignans.
双阴离子偶联在二苄基丁烷木脂素合成中的作用。
DOI:
10.1021/np50080a006
发表时间:
1992
期刊:
Journal of natural products
影响因子:
5.1
作者:
[Belletire,JL, Fry,DF, Fremont,SL]
通讯作者:
Fremont,SL
LIGNAN ANTITUMOR PROTOTYPES VIA DIANION INTERMEDIATES
-
批准号:3179640
-
项目类别:
-
资助金额:$6.72万
-
财政年份:1985
-
负责人:JOHN L BELLETIRE
-
依托单位:
LIGNAN ANTITUMOR PROTOTYPES VIA DIANION INTERMEDIATES
-
批准号:3179643
-
项目类别:
-
资助金额:$4.43万
-
财政年份:1985
-
负责人:JOHN L BELLETIRE
-
依托单位:
海外基金